Back to results
US 2019/0099464 A1Published application
Saffron extract and its use for the prevention of mood disorders related to depression
AssigneePharmactive Biotech Products, S.L.
InventorsAntonio Manuel INAREJOS GARCÍA, Marin PRODANOV PRODANOV, Amanda RAO, Jean-Marie RAYMOND
Life of this patent
Estimating the term…
Abstract
The present invention relates to a powdered composition obtained from saffron stigmas characterized in that it comprises from 0.03% to 1% dry weight of safranal; and at least 3.48% dry weight of crocins that encompasses the various trans-crocin-4 (major isomer), trans-crocin-3, trans-crocin-2′, cis-crocin-4, trans-crocin-2, trans-crocin-1 isomers and any of their mixtures.
Claims18
A powdered composition comprising an extract of saffron stigmas analyzed by HPLC and characterized in that it comprises:
- a) Between 0.03% and 1% dry weight of safranal, and
- b) At least 3.48% dry weight of crocins, wherein said crocins comprise trans-crocin-4, trans-crocin-3, trans-crocin-2′, cis-crocin-4, trans-crocin-2, trans-crocin-1 and/or any of their mixtures.
Dependencies are inferred from the claim text.